Instrumentarium gets FDA OK on breast system
The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.The newly
The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.
The newly approved items are part of Instrumentarium's Diamond Breast Care System. The stereotactic feature can image from any two angles, which gives it flexibility and saves procedure time. Although the system is film-based, an amorphous selenium full-field digital upgrade kit is in the works. n
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
